Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Journal of Advanced Nursing|April 18, 2025
Exploring the Development of Early Career Nurses: Insights 4 Years After GraduationTracey Tulleners, Liz Ryan, Di Stratton-Maher, et al.
Health Technology Assessment (Winchester, England)|October 19, 2018
Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test studyIbrahim Abubakar, Ajit Lalvani, Jo Southern, et al.
Nurse Education in Practice|May 1, 2025
Navigating a nursing career four years after graduation: A qualitative descriptive study exploring drivers of staying amid wanting to leaveDaniel Terry, Liz Ryan, Jessica Elliott, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 29, 2019
Blood Transcriptomic Stratification of Short-term Risk in Contacts of TuberculosisJennifer Roe, Cristina Venturini, Rishi K Gupta, et al.
BMJ Open Respiratory Research|May 16, 2025
Emergency department presentations of community-acquired lower respiratory tract disease in Bristol, UK: a prospective cohort study 2022-2023Catherine Hyams, Robert Challen, Maria Lahuerta, et al.
Frontiers in Immunology|June 20, 2022
Evaluation of Host Protein Biomarkers by ELISA From Whole Lysed Peripheral Blood for Development of Diagnostic Tests for Active TuberculosisHarriet N Garlant, Kalaiarasan Ellappan, Matthew Hewitt, et al.
The Journal of Infection|February 14, 2025
Incidence of RSV-related hospitalizations for ARIs, including CAP: Data from the German prospective ThEpiCAP studyCaihua Liang, Elizabeth Begier, Stefan Hagel, et al.
ERJ Open Research|December 17, 2025
Acute coronary syndrome after an infective exacerbation of COPD: a prospective cohort study of acute lower respiratory tract disease in hospitalised adultsCaitlin Morgan, Robert Challen, Elizabeth Begier, et al.
Vaccine|February 9, 2024
Surveillance of pneumococcal serotypes in adults hospitalised with acute lower respiratory tract infection in Bristol, UKCatherine Hyams, Maria Lahuerta, Christian Theilacker, et al.
The Lancet. Infectious Diseases|January 11, 2021
Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trialKimberly Davis, Marta Valente Pinto, Nick J Andrews, et al.
Pageof 7